Published in J Peripher Nerv Syst on June 01, 2013
Endothelial Dysfunction as a Link Between Cardiovascular Risk Factors and Peripheral Neuropathy in Diabetes. J Clin Endocrinol Metab (2016) 0.83
Conventional deep pressure algometry is not suitable for clinical assessment of nociception in painless diabetic neuropathy. Diabet Foot Ankle (2016) 0.75
Four-year sequential nerve conduction changes since first visit in Japanese patients with early type 2 diabetes. J Diabetes Investig (2016) 0.75
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
Vascular risk factors and diabetic neuropathy. N Engl J Med (2005) 7.69
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care (2010) 3.20
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia (1998) 3.05
Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med (1995) 2.29
Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology (1997) 2.23
Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes (2009) 1.99
Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve (2006) 1.78
Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes (1988) 1.52
Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract (1991) 1.32
Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy. Diabetes Metab Res Rev (2011) 1.32
Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther (2005) 1.23
A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care (2007) 1.21
DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep (2010) 1.18
Quantitative thermal perception testing in adults. J Clin Neurophysiol (1999) 1.12
Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes (1996) 1.07
Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care (2001) 1.06
Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care (1993) 1.06
Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Diabetes Care (1999) 1.06
Ranirestat for the management of diabetic sensorimotor polyneuropathy. Diabetes Care (2009) 1.01
Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology. Diabetes Care (2010) 1.00
ACCORD and Risk-Factor Control in Type 2 Diabetes. N Engl J Med (2010) 0.99
The evaluation of small fiber function-autonomic and quantitative sensory testing. Neurol Clin (2004) 0.99
Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes. Neurology (2003) 0.99
Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology (2000) 0.99
Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors. Diabet Med (2002) 0.95
The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med (1993) 0.94
Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. Diabetes Res Clin Pract (1995) 0.94
Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia (1997) 0.93
Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke (1996) 0.84
Comparison of risk factors for foot problems in diabetic patients attending teaching hospital outpatient clinics in four different European states. Diabet Med (1994) 0.81
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care (2010) 6.64
Diabetic autonomic neuropathy. Diabetes Care (2003) 6.59
Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation (2005) 5.07
The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care (2003) 3.18
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev (2011) 2.61
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care (2004) 2.55
Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology (2006) 2.22
Noise-enhanced balance control in patients with diabetes and patients with stroke. Ann Neurol (2006) 2.06
Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes (2008) 2.04
Perceived Stress Scale: reliability and validity study in Greece. Int J Environ Res Public Health (2011) 1.99
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci (2011) 1.82
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care (2011) 1.70
Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care (2003) 1.68
Guidelines for the treatment of diabetic ulcers. Wound Repair Regen (2007) 1.67
Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure. Clin Auton Res (2004) 1.66
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain (2013) 1.60
Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg (2002) 1.59
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol (2010) 1.56
Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation (2002) 1.52
Quantification of sudomotor innervation: a comparison of three methods. Muscle Nerve (2010) 1.49
Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care (2003) 1.49
The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res (2011) 1.45
The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care (2002) 1.39
Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab (2009) 1.37
Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet (2005) 1.37
Quantification of sweat gland innervation: a clinical-pathologic correlation. Neurology (2009) 1.32
α-Synuclein in cutaneous autonomic nerves. Neurology (2013) 1.32
Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation (2003) 1.30
Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care (2002) 1.30
Two styles of acupuncture for treating painful diabetic neuropathy--a pilot randomised control trial. Acupunct Med (2007) 1.25
Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med (2009) 1.22
Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation (2004) 1.21
Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes (2012) 1.21
Methods of investigation for cardiac autonomic dysfunction in human research studies. Diabetes Metab Res Rev (2011) 1.20
Capsaicin induces degeneration of cutaneous autonomic nerve fibers. Ann Neurol (2010) 1.19
Antibody titers predict clinical features of autoimmune autonomic ganglionopathy. Auton Neurosci (2009) 1.18
Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care (2008) 1.18
Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol (2008) 1.18
Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation. J Appl Physiol (1985) (2002) 1.17
Diabetic autonomic neuropathy. Semin Neurol (2003) 1.12
The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Diabetes Care (2007) 1.12
Nonpharmacological treatment of reflex syncope. Clin Auton Res (2004) 1.11
Foot small muscle atrophy is present before the detection of clinical neuropathy. Diabetes Care (2005) 1.10
The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Metab (2004) 1.06
QDIRT: quantitative direct and indirect test of sudomotor function. Neurology (2008) 1.06
The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes (2005) 1.05
In vivo acceleration of skin growth using a servo-controlled stretching device. Tissue Eng Part C Methods (2010) 1.03
Determinants of self-rated health in a representative sample of a rural population: a cross-sectional study in Greece. Int J Environ Res Public Health (2012) 1.03
Autoimmune autonomic ganglionopathy with reversible cognitive impairment. Arch Neurol (2011) 1.03
Vascular dysfunction in obstructive sleep apnea and type 2 diabetes mellitus. Obesity (Silver Spring) (2010) 1.02
Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol (2010) 1.01
O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS One (2010) 1.00
Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology. Diabetes Care (2010) 1.00
The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism (2003) 1.00
Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol (2003) 0.99
The evaluation of small fiber function-autonomic and quantitative sensory testing. Neurol Clin (2004) 0.99
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation (2003) 0.99
DPP4 inhibitors: a new approach in diabetes treatment. Adv Ther (2008) 0.98
Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. J Surg Res (2009) 0.98
Guidelines for the prevention of diabetic ulcers. Wound Repair Regen (2008) 0.96
Obstructive sleep apnea and aging effects on macrovascular and microcirculatory function. Sleep (2010) 0.95
Disorders of sweating. Semin Neurol (2003) 0.95
Novel immunohistochemical techniques using discrete signal amplification systems for human cutaneous peripheral nerve fiber imaging. J Histochem Cytochem (2011) 0.94
A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds (2005) 0.93
Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One (2013) 0.92
Blood volume and its relation to peak O(2) consumption and physical activity in patients with chronic fatigue. Am J Physiol Heart Circ Physiol (2002) 0.91
Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism (2004) 0.91
Differential impairment of the sudomotor and nociceptor axon-reflex in diabetic peripheral neuropathy. Muscle Nerve (2006) 0.90
Non-invasive brain stimulation and the autonomic nervous system. Clin Neurophysiol (2013) 0.90
Antioxidants and CVD in diabetes: where do we stand now. Curr Diab Rep (2007) 0.89
L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy. Neurology (2005) 0.89
Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factors. Obesity (Silver Spring) (2010) 0.88
Diabetic neuropathy and microcirculation. Curr Diab Rep (2003) 0.88
Therapeutic interventions and oxidative stress in diabetes. Front Biosci (Landmark Ed) (2009) 0.87
Neuropathic pain: an updated grading system for research and clinical practice. Pain (2016) 0.87
Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). BMC Med Res Methodol (2013) 0.87
Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing. J Vasc Surg (2013) 0.86
Orthostatic dyspnea: a neglected symptom of orthostatic hypotension. Clin Auton Res (2005) 0.86
Impaired distal thermoregulation in diabetes and diabetic polyneuropathy. Diabetes Care (2009) 0.85
Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg (2006) 0.84
Increased skin inflammation and blood vessel density in human and experimental diabetes. Int J Low Extrem Wounds (2013) 0.84
Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther (2014) 0.84